Dj. Klein et al., PROTEOGLYCAN SYNTHESIS BY BOVINE MYOCARDIAL ENDOTHELIAL-CELLS IS INCREASED BY LONG-TERM EXPOSURE TO HIGH-CONCENTRATIONS OF GLUCOSE, Journal of cellular physiology, 165(3), 1995, pp. 493-502
The role of the metabolic milieu in control of proteoglycan synthesis
was investigated using bovine myocardial endothelial cells (BMEC) grow
n for six to eight passages in media containing either 5.6 or 25 mM gl
ucose. Macromolecular Na[S-35]sulfate incorporation into proteoglycans
was increased by exposure to 25 mM when compared with 5.6 mM glucose
(7.05 +/- 0.40 [SD] vs. 3.5 +/- 0.50 x 10(-4) dpm/mu g DNA). In contra
st, [H-3]leucine incorporation was unaffected by glucose (11.27 +/- 0.
85 vs. 9.88 +/- 1.23 x 10(-5) dpm/mu g DNA). The distribution of isoto
pes between media and cell layer fractions was not different in the tw
o conditions. Addition of 19.4 mM mannitol to 5.6 mM glucose containin
g media had no effect on isotope incorporation. The HPLC-DEAE and Seph
arose CL-GB elution profiles of media S-35-proteoglycans synthesized u
nder each condition were similar. A Sepharose CL4B K-av 0.08 heparan s
ulfate proteoglycan accounted for 20% of the total S-35-incorporation.
Perlecan domain III mRNA was identified by Northern analysis and doma
in I by the polymerase chain reaction (PCR) in total BMEC RNA. A mixtu
re of chondroitin/dermatan sulfate proteoglycans accounted for 67% of
S-35-incorporation. They eluted from Sepharose CL-6B at K-av 0 and 0.2
2. Two [H-3]leucine labeled core proteins of 135 and 50 kD were identi
fied in each of these S-35-proteoglycan peaks. Biglycan but not decori
n mRNAs were detected by Northern analysis and by PCR. These data demo
nstrate that prolonged exposure to high glucose concentrations in vitr
o stimulate the accumulation of [S-35]sulfate into microvascular endot
helial cell proteoglycans without significant alterations in their ove
rall hydrodynamic or charge related properties. Modulation of proteogl
ycan synthesis by glucose may participate in the pathogenesis of the s
mall vessel complications of diabetes. (C) 1995 Wiley-Liss, Inc.